Sarcopenia Screened With SARC-F Questionnaire Is Associated With Quality of Life and 4-Year Mortality

Journal of the American Medical Directors Association

Volumn 17, Issue 12, 2016, Pages 1129-1135

  Wu, Tai Yin ^a,b   Liaw, Chen Kun ^c,d,e   Chen, Fang Chun ^b   Kuo, Kuan Liang ^b   Chie, Wei Chu ^a   Yang, Rong Sen ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^e FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

mortality; SARC F; Sarcopenia

Indexed keywords

CALCIUM; CARDIOVASCULAR AGENT; HYPNOTIC SEDATIVE AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; BODY COMPOSITION; CLIMBING; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; EMERGENCY CARE; FEMALE; FOLLOW UP; GRIP STRENGTH; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; MORTALITY; PATIENT AUTONOMY; PHYSICAL PERFORMANCE; PLEASURE; POLYPHARMACY; PROSPECTIVE STUDY; QUALITY OF LIFE; SARC F QUESTIONNAIRE; SARCOPENIA; SELF REPORT; SKELETAL MUSCLE; STRUCTURED QUESTIONNAIRE; TAIWAN; VERY ELDERLY; VITAMIN SUPPLEMENTATION; WALKING; HOME FOR THE AGED; QUESTIONNAIRE; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; FEMALE; HOMES FOR THE AGED; HUMANS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; SARCOPENIA; SURVEYS AND QUESTIONNAIRES; TAIWAN;

EID: 84994481829     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2016.07.029     Document Type: Article

References (25)

1. 1 Morley, J.E., Pharmacologic options for the treatment of sarcopenia. Calcif Tissue Int 98 (2016), 319–333.
2. 2 Morley, J.E., Abbatecola, A.M., Argiles, J.M., et al. Sarcopenia with limited mobility: An international consensus. J Am Med Dir Assoc 12 (2011), 403–409.
3. 3 Morley, J.E., Anker, S.D., von Haehling, S., Prevalence, incidence, and clinical impact of sarcopenia: Facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle 5 (2014), 253–259.
4. 4 Fielding, R.A., Vellas, B., Evans, W.J., et al. Sarcopenia: An undiagnosed condition in older adults. Current consensus definition: Prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 12 (2011), 249–256.
5. 5 Lee, W.J., Liu, L.K., Peng, L.N., et al. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: Results from the I-Lan longitudinal aging study. J Am Med Dir Assoc 14 (2013), 528.e1–528.e7.
6. 6 Landi, F., Liperoti, R., Fusco, D., et al. Sarcopenia and mortality among older nursing home residents. J Am Med Dir Assoc 13 (2012), 121–126.
7. 7 Landi, F., Cruz-Jentoft, A.J., Liperoti, R., et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: Results from ilSIRENTE study. Age Ageing 42 (2013), 203–209.
8. 8 Patel, H.P., Syddall, H.E., Jameson, K., et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: Findings from the Hertfordshire Cohort Study (HCS). Age Ageing 42 (2013), 378–384.
9. 9 Cruz-Jentoft, A.J., Landi, F., Topinkova, E., et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 13 (2010), 1–7.
10. 10 Liu, L.K., Lee, W.J., Liu, C.L., et al. Age-related skeletal muscle mass loss and physical performance in Taiwan: Implications to diagnostic strategy of sarcopenia in Asia. Geriatr Gerontol Int 13 (2013), 964–971.
11. 11 Arango-Lopera, V.E., Arroyo, P., Gutierrez-Robledo, L.M., et al. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 17 (2013), 259–262.
12. 12 Woo, J., Leung, J., Morley, J.E., Validating the SARC-F: A suitable community screening tool for sarcopenia?. J Am Med Dir Assoc 15 (2014), 630–634.
13. 13 Malmstrom, T.K., Morley, J.E., SARC-F: A simple questionnaire to rapidly diagnose sarcopenia. J Am Med Dir Assoc 14 (2013), 531–532.
14. 14 Malmstrom, T.K., Miller, D.K., Simonsick, E.M., et al. SARC-F: A symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle 7 (2016), 28–36.
15. 15 Cao, L., Chen, S., Zou, C., et al. A pilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. J Nutr Health Aging 18 (2014), 277–283.
16. 16 Lee, J.S., Auyeung, T.W., Kwok, T., et al. Associated factors and health impact of sarcopenia in older chinese men and women: A cross-sectional study. Gerontology 53 (2007), 404–410.
17. 17 Wu, T.Y., Chie, W.C., Kuo, K.L., et al. Quality of life (QOL) among community dwelling older people in Taiwan measured by the CASP-19, an index to capture QOL in old age. Arch Gerontol Geriatr 57 (2013), 143–150.
18. 18 Wu, T.Y., Chie, W.C., Yang, R.S., et al. Risk factors for single and recurrent falls: A prospective study of falls in community dwelling seniors without cognitive impairment. Prev Med 57 (2013), 511–517.
19. 19 Lee, M.B., Liao, S.C., Lee, Y.J., et al. Development and verification of validity and reliability of a short screening instrument to identify psychiatric morbidity. J Formos Med Assoc 102 (2003), 687–694.
20. 20 Wu, I.C., Lin, C.C., Hsiung, C.A., et al. Epidemiology of sarcopenia among community-dwelling older adults in Taiwan: A pooled analysis for a broader adoption of sarcopenia assessments. Geriatr Gerontol Int 14 (2014), 52–60.
21. 21 Wu, C.H., Chen, K.T., Hou, M.T., et al. Prevalence and associated factors of sarcopenia and severe sarcopenia in older Taiwanese living in rural community: The Tianliao Old People study. Geriatr Gerontol Int 14 (2014), 69–75.
22. 22 Cruz-Jentoft, A.J., Baeyens, J.P., Bauer, J.M., et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 39 (2010), 412–423.
23. 23 Woo, J., Leung J,Morley, J.E., Defining sarcopenia in terms of incident adverse outcomes. J Am Med Dir Assoc 16 (2015), 247–252.
24. 24 Lau, E.M., Lynn, H.S., Woo, J.W., et al. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60 (2005), 213–216.
25. 25 Melamed, M.L., Michos, E.D., Post, W., et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 168 (2008), 1629–1637.